1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

08 May 2023
Admin
News Article

Sun Pharma Recalls Over 24K Prefilled Syringes Of Generic Medication In The Us Due To A Manufacturing Issue

Drug Major Sun Pharmaceutical Industries Is Recalling Pre-Filled Syringes Of A Drug, Used To Treat Infertility In Women, In The Us Market Due To A Manufacturing Issue, According To The Us Health Regulator.In Its Latest Enforcement Report, The Us Food And Drug Administration (Usfda) Noted That The Mumbai-Based Drug Major Is Recalling 24,194 Prefilled Syringes Of Fyremadel (Ganirelix Acetate) Injection. The Company Is Recalling The Affected Lot Due To The Presence Of Particulate Matter, The Usfda Said. The Product Was Manufactured By Sun Pharma And Distributed In The Us Market By New Jersey-Based Ferring Pharmaceuticals Inc. The Company Initiated The Countrywide (Us) Recall On April 19 This Year, Usfda Stated. The New Jersey-Based Sun Pharmaceutical Inc, A Unit Of The Company, Has Already Announced The Recall Of 16,450 Vials Of Norepinephrine Bitartrate Injection For "Failed Impurities/Degradation Specifications".As Per The Usfda, The Drugmaker Is Also Voluntarily Recalling Over 34,000 Bottles Of A Generic Medication, Used To Treat High Blood Pressure, In The Us Market Due To Failed Dissolution Testing.The Indian Pharmaceutical Industry Is The World'S Third-Largest By Volume And 14Th-Largest In Terms Of Value. India Exported Pharmaceuticals Worth Rs 1,75,040 Crore In The Financial Year 2021-22, Including Bulk Drugs/ Drug Intermediates.The Us Is The World'S Largest Market For Pharmaceutical Products.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!